age

ROM: Golden Age on CROSS Officially Onboarded to the CROSS Blockchain Platform

Seoul, South Korea, Dec. 20, 2025 (GLOBE NEWSWIRE) -- ROM: Golden Age on CROSS, a global MMORPG, has officially been…

5 hours ago

Manipal Hospital Millers Road Hosts Senior Premier League to Celebrate Active Ageing

BENGALURU, India, Dec. 19, 2025 /PRNewswire/ -- Senior citizens in Bengaluru enjoyed a vibrant, fun-filled day of low-impact games and laughter…

1 day ago

Viola Mother Fletchers Interactive Storyfile Preserves Her Legacy in Tulsa

Tulsa, OK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Authentic Interactions, owner of StoryFile,  is proud to honor the remarkable life…

3 weeks ago

Singapore no. 1 in global competition for talent

FONTAINEBLEAU, France and SINGAPORE and SAN FRANCISCO, Nov. 26, 2025 /PRNewswire/ -- Singapore has leapfrogged Switzerland to take top spot…

3 weeks ago

Valneva Announces Positive Final Phase 2 Results for Lyme Disease Vaccine Candidate

Antibody levels remained well above baseline across all six serotypes and age groups sixth month after third yearly booster doseNo…

4 weeks ago

The Volpi Rosse Menarini: The ‘Fantastic Ten’ are ready for the 2025 – 2026 Season

Italian wheelchair basketball team, sponsored by Menarini, was presented to the press and public in Italy. The challenges they will…

4 weeks ago

Netcore Unbxd Launches ‘Enrichment for Agentic Commerce’ to Make Retailers Visible in the Age of AI Shopping

The new AI-powered platform structures and enriches product catalogues, enabling discovery by ChatGPT, Gemini, and other emerging shopping agents NEW…

1 month ago

Springer Nature honours Indian editors at Journal Development Symposium 2025. Brings Together Leading Editors and Publishing Experts to Shape the Future of Research Integrity and AI in Scholarly Communication

NEW DELHI, Oct. 31, 2025 /PRNewswire/ -- The day long Journal Development Symposium 2025, organised by Springer Nature, brought together…

2 months ago

ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal Antibody for Respiratory Syncytial Virus Infection

SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced the initiation of a Phase II…

2 months ago